Streamex Corp. (STEX) Fair Value 2026

STEX · Electromedical & Electrotherapeutic Apparatus ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.1 /10

32 fundamental signals · 7 models active

Value Trap Risk

LOW (35/100)

Quick Summary — As of 2026-07-15, Streamex Corp. (STEX) trades at $0.81, approximately 578% above CirclFi’s Bayesian DCF fair value of $0.12. QOC: 5.1/10. Value Trap Risk: 35/100 (LOW). 7/13 models active.

Key Facts

Ticker
STEX
Price
$0.81
Quality Score
5.1/10
Value Trap Risk
35/100
Models Active
7/13
Last Updated
Strength: 7 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

Is Streamex Corp. (STEX) Undervalued or Overvalued in 2026?

According to CirclFi’s 7-model valuation engine, Streamex Corp. (STEX) appears overvalued as of : the median of 7 independent fair value estimates is $0.28, 65.5% below the current price of $0.81. Estimates range from $0.01 to $3.03. STEX scores 5.1/10 on fundamental quality and 35/100 on value-trap risk.

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Streamex Corp. Stock in 2026? →

Valuation Matrix

7 Intrinsic Value Models vs. Current Price ($0.81)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
Low Conviction
 $0.12 -85.3%
CUCE Ensemble
Low Conviction
 $0.28 -65.5%
Dynamic NAV
Medium Conviction
 $0.15 -81.0%

Unlock the Full Matrix

Access 4 additional models including ML-RIV, PWERM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 7 Models →

Cancel anytime · No contracts · Instant access

What Is Streamex Corp. (STEX) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Streamex Corp.'s intrinsic value is estimated at a composite fair value of $0.78. Trading at $0.81, the stock is approaching fair value or slight overvaluation (implied return of -2.9%), as 4 of 7 models suggest limited further upside. The most optimistic model, ML-RIV, places fair value at $3.03 (+275.1%), while Regime Cross — the most conservative — estimates $0.01 (-98.8%). This +373.9% gap reflects genuine analytical uncertainty about Streamex Corp.'s intrinsic worth.

What Do the Models Say About STEX?

7 of 13 models are currently active for STEX. Of these, 3 models suggest upside while 4 models suggest overvaluation. The Bayesian DCF estimates STEX's intrinsic value at $0.12, implying -85.3% downside from the current price. See which stocks rank higher →

How Does STEX Rank in Electromedical & Electrotherapeutic Apparatus?

Among 25 Electromedical & Electrotherapeutic Apparatus stocks, STEX ranks #21 by Quality of Company score. CirclFi's QOC score of 5.1/10 evaluates 32 fundamental signals. A score of 5.1 reflects mixed fundamentals.

Streamex Corp. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is STEX a Value Trap?

CirclFi's Value Trap algorithm assigns STEX a score of 35/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

7 of 13 models are active for Streamex Corp.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Streamex Corp. earns a quality score of 5.1/10. This mixed rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +373.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every STEX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across STEX's 7 active models, average confidence is 24%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Streamex Corp. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Electromedical & Electrotherapeutic Apparatus Stocks Should You Also Analyze?

8 related Electromedical & Electrotherapeutic Apparatus stocks with 13-model coverage

INMDInMode Ltd.QOC 9.9ELMDElectromed, Inc.QOC 9.4LIVNLivaNova PLCQOC 9.1CNMDCONMED CorporationQOC 8.9ITGRInteger Holdings CorporationQOC 8.3MDTMedtronic plc.QOC 8.1TMDXTransMedics Group, Inc.QOC 8.0AXGNAxoGen, Inc.QOC 7.9

Read investment analysis: INMD · ELMD · LIVN · CNMD · ITGR

Frequently Asked Questions About Streamex Corp.

What is Streamex Corp.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Streamex Corp. (STEX) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $0.12. The Quality of Company score is 5.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is STEX overvalued or undervalued right now?

At $0.81, 3 of 7 active models suggest STEX may be undervalued, while 4 indicate potential overvaluation. The median of all 7 fair value estimates is $0.28, 65.5% below the current price of $0.81 — a consensus view that STEX is overvalued. The assessment depends on which methodology best fits Streamex Corp.'s business model in Electromedical & Electrotherapeutic Apparatus.

What does a Quality of Company score of 5.1 mean for STEX?

Streamex Corp.'s QOC of 5.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on STEX?

CirclFi analyzes STEX with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 7 of 13 are active for this stock. Read the full methodology →

Is STEX a value trap in 2026?

Streamex Corp.'s Value Trap score is 35/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 7-model valuation engine, Streamex Corp. (STEX) has a median fair value of $0.28 — 65.5% below the current price of $0.81 — as of 2026-07-15.” Source: circlfi.com/stock/STEX/ · Methodology

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 7 mathematical frameworks give you clarity on STEX.

Unlock All 7 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access